Cannabis News and Research RSS Feed - Cannabis News and Research

DigiPath, Blue Line sign preferred supplier marketing and resource-sharing agreement

DigiPath, Blue Line sign preferred supplier marketing and resource-sharing agreement

DigiPath, Inc., the independent digital pathology and cannabis testing, education, and media firm, has entered into a preferred supplier marketing and resource-sharing agreement with Blue Line Protection Group. [More]
Cannabis use increases manic, depressive symptoms

Cannabis use increases manic, depressive symptoms

The first study to examine the use of cannabis in the context of daily life among people with Bipolar Disorder has shown how the drug is linked to increases in both manic and depressive symptoms. [More]
TNMNews examines how cannabis laws impact students, families

TNMNews examines how cannabis laws impact students, families

The latest segment of TNMNews, the unbiased marijuana talk radio program from DigiPath, Inc., focuses on how laws based on the War on Drugs have hurt students and families. [More]
CannTrust, Canabo to partner on medical marijuana research project

CannTrust, Canabo to partner on medical marijuana research project

CannTrust, Canada's only pharmacist-controlled licensed producer and distributor of medical cannabis today announced a collaboration with Canabo Medical Corporation to partner on a research project on marijuana for medical purposes. [More]
Cannabis abuse affects long-term memory, finds new Northwestern Medicine study

Cannabis abuse affects long-term memory, finds new Northwestern Medicine study

Teens who were heavy marijuana users - smoking it daily for about three years -- had an abnormally shaped hippocampus and performed poorly on long-term memory tasks, reports a new Northwestern Medicine study. [More]
One World Cannabis, Sheba Academic Medical Center ink collaboration agreement

One World Cannabis, Sheba Academic Medical Center ink collaboration agreement

OWC Pharmaceutical Research Corp.'s wholly owned subsidiary One World Cannabis Ltd. signed a collaboration agreement with Sheba Academic Medical Center, the largest hospital in Israel and in the Middle East. [More]
InMed, University of Debrecen partner to develop novel therapies to treat ocular allergies

InMed, University of Debrecen partner to develop novel therapies to treat ocular allergies

InMed Pharmaceuticals Inc. announces it has formed an exclusive strategic collaboration with the University of Debrecen, Hungary, to develop novel phytocannabinoid-based therapies to treat ocular allergic symptoms. [More]
Researchers develop robust screening method for routine measurement of drugs in exhaled breath

Researchers develop robust screening method for routine measurement of drugs in exhaled breath

Drug testing is most commonly performed using urine samples. The methodology and regulations for reliable urine testing are well developed and can be considered the current gold standard for drug testing. [More]
Study demonstrates that activation of cannabinoid CB2 receptors suppresses chronic pain

Study demonstrates that activation of cannabinoid CB2 receptors suppresses chronic pain

Medical marijuana is proliferating across the country due to the ability of cannabis ingestion to treat important clinical problems such as chronic pain. However, negative side effects and the development of tolerance limit the widespread therapeutic use of Δ9-tetrahydrocannabinol (Δ9-THC), the major psychoactive ingredient in cannabis. [More]
New article shows how marijuana can act as an allergen

New article shows how marijuana can act as an allergen

Growing up, you may have been given reasons for not smoking marijuana. What you may not have heard is that marijuana, like other pollen-bearing plants, is an allergen which can cause allergic responses. [More]
Steep Hill plans to open laboratory for testing quality of medical cannabis

Steep Hill plans to open laboratory for testing quality of medical cannabis

Steep Hill, the industry leader in cannabis testing and analytics in the US and internationally, intends to open a full service medical cannabis quality assurance laboratory in Albuquerque, New Mexico, bringing advanced scientific tools and methodology to the state, for regulatory oversight of cannabis. [More]
LSU Health New Orleans finalizes deal with CB BioSciences

LSU Health New Orleans finalizes deal with CB BioSciences

The Office of Technology Management at LSU Health New Orleans has finalized a deal with CB BioSciences, Inc., a startup drug development company to build a platform around the intellectual property portfolio of Chu Chen, PhD, LSU Health New Orleans Professor of Neuroscience. [More]

CannTrust receives Health Canada approval to produce, distribute medical cannabis in Canada

CannTrust Inc., a privately held, wholly-owned Canadian company, has been approved by Health Canada as a Licensed Producer and distributor of medical cannabis in Canada, under the Marihuana for Medical Purposes Regulations. [More]
Study examines relationship between substance use and teen pregnancy

Study examines relationship between substance use and teen pregnancy

New research from The University of Texas at Austin suggests that many teenagers, especially younger teens, may not be getting the message about the risks of using alcohol and other drugs during pregnancy -- but that having involved parents and being engaged academically can help. [More]
Midwest Compassion Center, Dr. Alan Shackelford join forces to treat epilepsy through medical cannabis

Midwest Compassion Center, Dr. Alan Shackelford join forces to treat epilepsy through medical cannabis

Midwest Compassion Center and Dr. Alan Shackelford join forces in the fight to treat epilepsy through the use of medical cannabis at their Will County dispensary. With growing concerns over the potentially negative side effects of pharmaceuticals and their inability to provide adequate symptom control in as many as 30% of patients with seizures, Dr. Shackelford and MCC will collaborate on research with the goal of developing new treatment options for patients dealing with a debilitating illness or condition, including seizures. [More]
Experts discuss therapeutic potential of medical cannabis in a symposium organized by MUHC

Experts discuss therapeutic potential of medical cannabis in a symposium organized by MUHC

While debate about recreational marijuana use continues, researchers are investigating the effectiveness of cannabis for treating pain, spasticity, and a host of other medical problems. In a symposium organized by the McGill University Health Centre as part of the 2015 American Association for the Advancement of Science Annual Meeting held this week in San Jose, California, world-renowned experts from North America and the U.K. share their perspectives on the therapeutic potential of medical cannabis and explore the emerging science behind it. [More]

Resource Ventures announces corporate update, anticipates record annual revenues

Resource Ventures, Inc. Interim President Michael Cipolla is pleased to announce today that the company anticipates reporting record annual revenues. [More]
Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

Cannabis Science highlights more attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm

Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015. [More]
Researchers suggest significant relationship between cannabis use and mania symptoms

Researchers suggest significant relationship between cannabis use and mania symptoms

Researchers from the University of Warwick have found evidence to suggest a significant relationship between cannabis use and the onset and exacerbation of mania symptoms. [More]
Five researchers selected to receive 2015 Avant-Garde Award for HIV/AIDS Research

Five researchers selected to receive 2015 Avant-Garde Award for HIV/AIDS Research

With proposals ranging from innovative therapies to the development of unique organoid models of the brain, five scientists have been selected to receive the 2015 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse, part of the National Institutes of Health. The five scientists will each receive $500,000 per year for five years to support their research. [More]
Advertisement
Advertisement